Related Experiment Videos
[Proceedings: Long-term therapy with antibiotics in chronic bronchitis]
Schweizerische Medizinische Wochenschrift
|July 12, 1975
Summary
Longterm therapy for chronic bacterial bronchitis involves treating acute flare-ups and continuous prophylaxis for severe cases. Common bacteria like Haemophilus influenzae and pneumococci are typically treatable with antibiotics such as ampicillin and tetracyclines.
Area of Science:
- Pulmonary Medicine
- Infectious Diseases
- Pharmacology
Background:
- Chronic bacterial bronchitis requires long-term management strategies.
- Therapy includes addressing acute exacerbations and implementing long-term prophylaxis.
- Prophylaxis is primarily recommended during winter months (4-7 months).
Purpose of the Study:
- To outline the two primary forms of long-term therapy for chronic bacterial bronchitis.
- To define criteria for implementing long-term prophylactic treatment.
- To identify common pathogens and effective antibiotic options.
Main Methods:
- Review of established therapeutic approaches for chronic bacterial bronchitis.
- Identification of patient subgroups qualifying for long-term prophylaxis.
- Analysis of antibiotic sensitivity patterns for prevalent bacterial pathogens.
Main Results:
- Long-term therapy encompasses acute exacerbation management and continuous prophylaxis.
- Continuous prophylaxis is indicated for patients experiencing two or more severe annual exacerbations.
- Haemophilus influenzae and pneumococci, the most frequent pathogens, demonstrate sensitivity to ampicillin, amoxycillin, cotrimoxazole, and tetracyclines.
Conclusions:
- Long-term management of chronic bacterial bronchitis should be individualized.
- Prophylactic antibiotic therapy is a key strategy for patients with frequent severe exacerbations.
- Standard antibiotics remain effective against common causative agents, guiding treatment choices.